HK1049442B - 含有諾塞甾酮和睪酮十一烷酯的男性避孕藥組成 - Google Patents

含有諾塞甾酮和睪酮十一烷酯的男性避孕藥組成

Info

Publication number
HK1049442B
HK1049442B HK03101578.5A HK03101578A HK1049442B HK 1049442 B HK1049442 B HK 1049442B HK 03101578 A HK03101578 A HK 03101578A HK 1049442 B HK1049442 B HK 1049442B
Authority
HK
Hong Kong
Prior art keywords
norethisterone
testosterone
testosterone undecanoate
male contraceptive
males
Prior art date
Application number
HK03101578.5A
Other languages
English (en)
Other versions
HK1049442A1 (en
Inventor
Eberhard Nieschlag
Axel Kamischke
Michael Oettel
Alexander Ruebig
Ekkerhard Schillinger
Ursula-Friederike Habenicht
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of HK1049442A1 publication Critical patent/HK1049442A1/xx
Publication of HK1049442B publication Critical patent/HK1049442B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK03101578.5A 2000-02-15 2003-03-04 含有諾塞甾酮和睪酮十一烷酯的男性避孕藥組成 HK1049442B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50372900A 2000-02-15 2000-02-15
EP00200493 2000-02-15
PCT/IB2001/000188 WO2001060376A1 (en) 2000-02-15 2001-02-15 Male contraceptive formulation comprising norethisterone

Publications (2)

Publication Number Publication Date
HK1049442A1 HK1049442A1 (en) 2003-05-16
HK1049442B true HK1049442B (zh) 2007-06-15

Family

ID=26071832

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101578.5A HK1049442B (zh) 2000-02-15 2003-03-04 含有諾塞甾酮和睪酮十一烷酯的男性避孕藥組成

Country Status (26)

Country Link
EP (2) EP1267885B8 (zh)
JP (1) JP2003522795A (zh)
KR (1) KR20020086905A (zh)
CN (1) CN1423560A (zh)
AT (2) ATE355844T1 (zh)
AU (1) AU2001230447A1 (zh)
BG (1) BG107066A (zh)
BR (1) BR0108411A (zh)
CA (1) CA2398063A1 (zh)
CY (1) CY1106639T1 (zh)
CZ (1) CZ20022691A3 (zh)
DE (2) DE60142647D1 (zh)
DK (1) DK1267885T3 (zh)
EE (1) EE200200454A (zh)
ES (1) ES2282230T3 (zh)
HK (1) HK1049442B (zh)
HU (1) HUP0300128A3 (zh)
IL (1) IL151219A0 (zh)
MX (1) MXPA02007675A (zh)
NO (1) NO20023607L (zh)
PL (1) PL357185A1 (zh)
PT (1) PT1267885E (zh)
RU (1) RU2002124602A (zh)
SI (1) SI1267885T1 (zh)
SK (1) SK11602002A3 (zh)
WO (1) WO2001060376A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
TW200404552A (en) * 2002-05-30 2004-04-01 Akzo Nobel Nv Self administered contraception
NZ537871A (en) 2002-07-24 2006-10-27 Schering Ag Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids
US20060100180A1 (en) * 2002-07-25 2006-05-11 Reinhard Nubbemeyer Composition containing an androgenous 11b-halogen steroid and a progestational hormone, and male contraceptive based on said composition
CN101352443B (zh) * 2007-07-23 2011-01-12 中国科学院动物研究所 哺乳动物雄性不育剂
SG11202008794TA (en) 2018-03-23 2020-10-29 Laboratoires Major Non-hormonal compositions and methods for male contraception

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714420A1 (de) * 1976-06-01 1977-12-08 Int Pregnancy Advisory Service Antikonzeptionsmittel zur verabreichung an mann und frau in einer gemeinsamen verabreichungspackung
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
US5035891A (en) 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
DE19650352A1 (de) * 1996-12-04 1998-07-30 Jenapharm Gmbh Oral wirksames Kombinationspräparat zur Kontrazeption für den Mann

Also Published As

Publication number Publication date
JP2003522795A (ja) 2003-07-29
DE60127103T2 (de) 2007-11-22
ATE474580T1 (de) 2010-08-15
SI1267885T1 (sl) 2007-08-31
DK1267885T3 (da) 2007-07-09
NO20023607D0 (no) 2002-07-30
CA2398063A1 (en) 2001-08-23
EP1267885A1 (en) 2003-01-02
AU2001230447A1 (en) 2001-08-27
DE60127103D1 (de) 2007-04-19
EP1666044A1 (en) 2006-06-07
CN1423560A (zh) 2003-06-11
IL151219A0 (en) 2003-04-10
RU2002124602A (ru) 2004-03-10
HK1049442A1 (en) 2003-05-16
CZ20022691A3 (cs) 2003-01-15
EP1267885B8 (en) 2007-06-20
ATE355844T1 (de) 2007-03-15
DE60142647D1 (de) 2010-09-02
EP1666044B1 (en) 2010-07-21
ES2282230T3 (es) 2007-10-16
CY1106639T1 (el) 2012-01-25
EP1267885B1 (en) 2007-03-07
EE200200454A (et) 2003-12-15
KR20020086905A (ko) 2002-11-20
NO20023607L (no) 2002-10-15
HUP0300128A2 (en) 2003-05-28
PL357185A1 (en) 2004-07-26
BR0108411A (pt) 2003-03-11
WO2001060376A1 (en) 2001-08-23
MXPA02007675A (es) 2004-02-26
SK11602002A3 (sk) 2003-03-04
BG107066A (en) 2003-05-30
PT1267885E (pt) 2007-05-31
HUP0300128A3 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
CY1106639T1 (el) Τυποποιηση αντισυλληπτικου για ανδρες που περιλαμβανει νορεθιστερονη
IL188250A0 (en) Dosage unit for inhibiting ovulation comprising drospirenone and a complex between ethinyl estradiol and cyclodextrine
CA2084891A1 (en) Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
AU9041991A (en) Transdermal contraceptive formulations, methods and devices
GEP20053586B (en) Selective Androgen Receptor Modulators and Pharmaceutical Compositions Containing the Same
WO2001003687A3 (en) Method and compositions for inhibiting biosynthesis or bioactivity of endogenous steroid sex hormones in humans
FI884378A (fi) Farmaceutiskt preparat och foerfarande foer framstaellning av detsamma.
DE122007000011I1 (de) Feste Arzneiformen, enthaltend Clathrate vom steroidalen Sexualhormon Ethinylestradiol
DE59805902D1 (de) Nichtestrogene derivate des estradiols mit antioxidativer aktivität
NZ334876A (en) Hormonal composition consisting of an estrogenic derivative and a progestative agent
WO2001040255A3 (en) 14,15-beta-methylene substituted androgens
ZA200201250B (en) Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11.
AR027526A1 (es) Formulacion anticonceptiva masculina que comprende noretisterona
EP1513588B1 (en) Use of new etonogestrel esters
JP2003522795A5 (zh)
GB9807809D0 (en) Compositions comprising ethisterone or its derivatives
WO2000003678A3 (en) Subcutaneous medroxyprogesterone acetate for contraception
GB1060632A (en) Steroid compositions
PE20020709A1 (es) Composiciones de complejos de estrogeno-ciclodextrina

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130215